10-3


10-3.		Prevent an increase in the proportion of isolates of Salmonella species from humans and from animals at slaughter that are resistant to antimicrobial drugs.

Target and baseline:

Objective	Prevention of Increase in Proportion of Salmonella Species Resistant to Antimicrobial Drugs	1997 Baseline	2010 Target
		Percent of Isolates
	*Salmonella* from humans that are resistant to:
10-3a.	Fluoroquinolones	0	0
10-3b.	Third-generation cephalosporins	0	0
10-3c.	Gentamicin	3	3
10-3d.	Ampicillin	18	18
	*Salmonella* from cattle at slaughter that are resistant to:
10-3e.	Fluoroquinolones	Developmental
10-3f.	Third-generation cephalosporins	Developmental
10-3g.	Gentamicin	Developmental
10-3h.	Ampicillin	Developmental
	*Salmonella* from broilers at slaughter that are resistant to:
10-3i.	Fluoroquinolones	Developmental
10-3j.	Third-generation cephalosporins	Developmental
10-3k.	Gentamicin	Developmental
10-3l.	Ampicillin	Developmental
	*Salmonella* from swine at slaughter that are resistant to:
10-3m.	Fluoroquinolones	Developmental
10-3n.	Third-generation cephalosporins	Developmental
10-3o.	Gentamicin	Developmental
10-3p.	Ampicillin	Developmental

Target setting method: No increase.

Data sources: National Antimicrobial Resistance Monitoring System: Enteric Bacteria�Salmonella (NARMS: Enteric Bacteria), CDC, NCID; FDA, CVM; USDA, FSIS, APHIS, and ARS; Foodborne Disease Active Surveillance Network (FoodNet), CDC, FDA, USDA, FSIS.